Announcements Trials
Browse Landscape

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 74Expanded_access 4Observational 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Ovarian Neoplasms 1Neoplasms 1

Interventions

Surveys and Questionnaires 34Blood Specimen Collection 24enzalutamide 18Radiotherapy 15Docetaxel 15Biopsy 14Abiraterone Acetate 14apalutamide 13Leuprolide 13Interviews as Topic 13Observation 12Magnetic Resonance Spectroscopy 12Watchful Waiting 10radium Ra 223 dichloride 9darolutamide 9Androgen Antagonists 9acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8Radiosurgery 7Magnetic Resonance Imaging 7Brachytherapy 7abiraterone 6Specimen Handling 6Amplified Fragment Length Polymorphism Analysis 6Triptorelin Pamoate 5Standard of Care 5Positron Emission Tomography Computed Tomography 5Gonadotropin-Releasing Hormone 5Focus Groups 5Registries 4Radiotherapy, Intensity-Modulated 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Prostatic Neoplasms × gallium 68 PSMA-11 × Clear all
NCT04484701 2025-05-09

[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer

British Columbia Cancer Agency

Active not recruiting
1,574 enrolled
Genitourinary

Prostatic Neoplasms

NCT05527483 2024-05-16

Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer Patients

University Hospitals Cleveland Medical Center

Completed
32 enrolled
Genitourinary

Prostatic Neoplasms

NCT04867603 2023-12-19

Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions

Case Comprehensive Cancer Center

Completed
16 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡